DBV Technologies to Meet with Investors in November

DBV Technologies, a biopharmaceutical company listed on Euronext and Nasdaq, announces its participation in two investor conferences in November 2026. On November 9, the company will be in Boston for the 3rd annual Guggenheim Securities Healthcare Innovation Conference, where it will participate in an informal discussion. On November 16, DBV Technologies will attend the LifeSci Growth & Innovation Summit in London for one-on-one meetings.

For those unable to attend in person, DBV Technologies will offer a live webcast of the "fireside chat." This content will be available on their website for 90 days after the event.